Combination Effect of Finerenone and Empagliflozin in Participants With Chronic Kidney Disease and Type 2 Diabetes Using a UACR Endpoint Study (CONFIDENCE)
Back
7 Feb 2025
14:15
14:45
Rajiv
Agarwal
Oral Abstract Presenter
United States